SONYA TATUM: Open Payments
NPI 1760755433 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 79 payments from 29 companies in 2025. Trend: 2023 $1,814 · 2024 $1,260 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $147 |
| Axsome Therapeutics, Inc. | 6 | $118 |
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| Otsuka America Pharmaceutical, Inc. | 6 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $101 |
| Lundbeck LLC | 4 | $83 |
| Sumitomo Pharma America, Inc. | 5 | $77 |
| Lilly USA, LLC | 4 | $71 |
| PFIZER INC. | 3 | $57 |
| Neurocrine BioSciences, Inc. | 3 | $52 |
Products named: REXULTI, Auvelity, Kerendia, FARXIGA, VRAYLAR, GEMTESA, UBRELVY, INGREZZA.
Industry payments across AL — which companies pay providers there.
